107 related articles for article (PubMed ID: 19525492)
1. Compression of superficial temporal arteries by a handmade device: a simple way to block or attenuate migraine attacks in children and adolescents.
Cianchetti C; Serci MC; Pisano T; Ledda MG
J Child Neurol; 2010 Jan; 25(1):67-70. PubMed ID: 19525492
[TBL] [Abstract][Full Text] [Related]
2. Treatment of migraine attacks by compression of temporal superficial arteries using a device.
Cianchetti C; Cianchetti ME; Pisano T; Hmaidan Y
Med Sci Monit; 2009 Apr; 15(4):CR185-8. PubMed ID: 19333203
[TBL] [Abstract][Full Text] [Related]
3. Pressure-painful scalp arteries in children and adolescents suffering from migraine.
Cianchetti C; Serci MC; Madeddu F; Cossu S; Ledda MG
Cephalalgia; 2011 Nov; 31(15):1576-9. PubMed ID: 21914730
[TBL] [Abstract][Full Text] [Related]
4. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
5. Is the Migraid device an asset in the non-pharmacologic treatment of migraine?
Pieterse H; Kuster JA; Van Bortel LM
Acta Neurol Belg; 2007 Jun; 107(2):40-6. PubMed ID: 17710839
[TBL] [Abstract][Full Text] [Related]
6. Extracranial vascular changes and the source of pain in migraine headache.
Drummond PD; Lance JW
Ann Neurol; 1983 Jan; 13(1):32-7. PubMed ID: 6830162
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a prolonged compression of scalp arteries on migraine attacks.
Hmaidan Y; Cianchetti C
J Neurol; 2006 Jun; 253(6):811-2. PubMed ID: 16807688
[No Abstract] [Full Text] [Related]
8. Scalp periarterial saline efficacy in migraine and relation to exploding and imploding headache.
Cianchetti C; Hmaidan Y; Finco G; Ledda MG
J Neurol; 2009 Jul; 256(7):1109-13. PubMed ID: 19252768
[TBL] [Abstract][Full Text] [Related]
9. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes of tension type and migraine headache in children.
Sri-udomkajorn S; Ruangsuwan S
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S104-8. PubMed ID: 19253504
[TBL] [Abstract][Full Text] [Related]
11. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up.
Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR
Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514
[TBL] [Abstract][Full Text] [Related]
12. Migraine pain location at onset and during established headaches in children and adolescents: a clinic-based study from eastern India.
Chakravarty A; Mukherjee A; Roy D
Cephalalgia; 2007 Oct; 27(10):1109-14. PubMed ID: 17850349
[TBL] [Abstract][Full Text] [Related]
13. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
14. Early treatment of migraine with rizatriptan: a placebo-controlled study.
Mathew NT; Kailasam J; Meadors L
Headache; 2004; 44(7):669-73. PubMed ID: 15209688
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
Linde M; Mellberg A; Dahlöf C
Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
[TBL] [Abstract][Full Text] [Related]
16. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
17. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
18. Short migraine attacks of less than 2 h duration in children and adolescents.
Abu-Arafeh I; Callaghan M
Cephalalgia; 2004 May; 24(5):333-8. PubMed ID: 15096221
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-hydroxytryptamine receptors in human temporal arteries: comparison between migraine suffers and nonsufferers.
Skärby T; Tfelt-Hansen P; Gjerris F; Edvinsson L; Olesen J
Ann Neurol; 1982 Sep; 12(3):272-7. PubMed ID: 7137963
[TBL] [Abstract][Full Text] [Related]
20. Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
Silberstein SD; Young WB; Hopkins MM; Gebeline-Myers C; Bradley KC
Headache; 2007 Jun; 47(6):878-85. PubMed ID: 17578539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
